Home > Products > EGFR & MET
> Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (CrossMab)
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (CrossMab) (CAT#: CROSSAB-154)
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Colorectal cancer; Pancreatic cancer; Head and neck cancer; Non-small cell lung cancer (NSCLC) therapy.
There are currently no customer reviews or questions for Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (CrossMab) (CROSSAB-154). Click the button below to contact us or submit your feedback about this product.